Arkolith/Insider Trading/TYRA/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Jun 16, 2025
Net Buying
Open-Market Buys
$1.7M
Open-Market Sells
$0
Net Open-Market Flow
$1.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2025Buy(P)12K$10.13$120K10.3M
Jun 13, 2025Buy(P)120K$10.20$1.2M10.2M
Jun 12, 2025Buy(P)31K$10.20$319K10.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-017446) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML